You want to lose the body fat, not the muscle
Damage-associated molecular patterns in inflammatory diseases
It is also hard to predict how people will think about these drugs over the long term, with a recent study by The New Consumer and Coefficient Capital showing that 46% of 1,810 consumers aware of GLP-1 weight loss drugs are extremely or very concerned about their long-term health impact, a figure that rises to 51% among users of such drugs (n-388)
You start at 0.25 mg weekly for the first four weeks, then increase to 0.5 mg for weeks 5 through 8, then 1 mg for weeks 9 through 12, then 1.7 mg for weeks 13 through 16, and finally the maintenance dose of 2.4 mg from week 17 onward
TL;DR GLP-1 Lawsuits at a Glance The drugs: GLP-1 receptor agonists and dual GIP/GLP-1 agents, including semaglutide, tirzepatide, dulaglutide, liraglutide, lixisenatide, and exenatide